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Abstract
Background: Silver is a transition metal, toxic when ingested in significant amounts, causing argyria (skin deposition)
and argyrosis (eye deposition). It is excreted mainly via the gastrointestinal tract with only small amounts eliminated by
the kidneys, and rarely have cases of nephrotoxicity due to silver been reported. Here we present the case of a woman
who used colloidal silver as an alternative remedy for a T cell lymphoma, who subsequently developed argyria and a
pauci-immune crescentic glomerulonephritis with evidence of extensive glomerular basement membrane silver
deposition.
Case Presentation: A 47 year old woman of Indo-Asian descent with a T-cell lymphoma who refused conventional
chemotherapy for 18 months but self-medicated with a remedy containing colloidal silver, was admitted with acute
dialysis-dependent kidney injury. A kidney biopsy demonstrated a pauci-immune crescentic glomerulonephritis with
deposition of silver particles in the mesangium and along the glomerular basement membranes. The patient was
treated with intravenous methylprednisolone and intravenous cyclophosphamide and recovered independent renal
function.
Conclusion: Chronological evolution of the the pauci-immune glomerulonephritis suggests that a cellular immune-
mediated process was induced, potentially mediated by lymphomatous T cells directed at the glomerular basement
membrane, following silver deposition. Immunosuppressive therapy improved the situation and allowed cessation of
haemodialysis, supporting the hypothesis of an immune-mediated process.
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Background
Silver is a transition metal element with a range of in-
dustrial and ornamental uses. Silver also has pharma-
ceutical applications, primarily as a disinfectant and
antimicrobial, and is known to be toxic when ingested in
significant amounts. The recognised manifestations of
this are irreversible deposition in the eye, causing
argyrosis, and in the skin, mucous membranes and in-
ternal organs, causing argyria.
Ingested silver is thought to be excreted mainly via the
gastrointestinal tract with only small amounts eliminated
by the kidneys [1]. Nevertheless some cases of nephro-
toxicity due to silver have been reported [2–6]. Here we
present the case of a woman who used colloidal silver as
a remedy for an un-treated T cell lymphoma and who
subsequently developed argyria and a pauci-immune
crescentic glomerulonephritis.
Case presentation
A 47-year-old woman of Indo-Asian decent was admit-
ted to the hospital with a two week history of peripheral
oedema, shortness of breath and lethargy, as well as an
itchy pigmented rash on her arms, legs and groin of two
months’ duration. She reported a large swelling of the
right side of her neck, which had been biopsied eighteen
months earlier and diagnosed as a T cell lymphoma, for
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which she had refused conventional chemotherapy. She
denied taking any regular prescribed medications, but
began using alternative remedies since the appearance of
the neck mass.
On examination the rash was raised and hyperpig-
mented with evidence of excoriation, and the patient
had a grey tint to her skin. She had a blood pressure of
164/96 mmHg. The neck mass was firm and non-tender,
measured 10cm x 4cm, and had two overlying scars
from previous biopsies.
Laboratory results demonstrated a serum creatinine of
600 μmol/l, urea 21.2 mmol/l, haemoglobin 6.3 g/dl,
neutrophils 21.9 x 109/l, CRP 118 mg/l, LDH 675 iU/l,
and serum bicarbonate 10 mmol/l. Urinalysis confirmed
proteinuria and haematuria and urinary protein creatin-
ine ration (UPCR) revealed nephrotic range proteinuria
of 515 mg/mmol. Virological tests for HIV, HCV and
Hepatitis B sAg were negative. Serological tests for anti-
dsDNA, ANA, ANCA and anti-GBM antibodies were all
negative, complement levels C3 and C4 were normal.
The patient was commenced on haemodialysis. A CT
scan of the chest, abdomen and pelvis confirmed that
the neck mass was an enlarged lymph node, with add-
itional axillary and mediastinal lymphadenopathy.
Biopsies of the kidneys, neck mass and skin lesions were
performed. The kidney biopsy revealed pauci-immune
crescentic glomerulonephritis, and glomerular tufts with
fine, dark, granular material scattered within the mesan-
gium and along the basement membrane (Fig. 1). Electron
microscopy confirmed the presence of scattered electron-
dense granules along and within the glomerular basement
membrane as well as in the mesangium (Fig. 2). This was
strikingly similar to the skin biopsy showing scattered fine
black granules within the basement membranes of the
sweat gland epithelial cells consistent with argyria.
Electron probe microanalysis demonstrated that these
granules contained predominantly silver and some selenium
atoms (Fig. 3). The biopsy of the neck mass confirmed a
peripheral T-cell lymphoma.
On further questioning the patient admitted using col-
loidal silver as another treatment for the neck swelling,
made by electrolytic solubilisation of a pair of silver elec-
trodes and consumption of the resulting solution (Fig. 4).
The patients’ serum silver concentration was strikingly
elevated at 127.1 nmol/l (reference value <2.8 nmol/l).
The patient was treated with 3 pulses of intravenous
methylprednisolone and intravenous cyclophosphamide,
adjusted for age and renal function, every 2-3 weeks,
followed by a tapering dose of oral prednisolone. After
three weeks, partial recovery of renal function permitted
withdrawal of haemodialysis. The patient declined con-
ventional chemotherapy for her lymphoma, but continued
Fig. 1 Auramine stain and congo red stain of a single glomerulus demonstrating crescentic change and silver deposition. a High magnification
of silver-stained renal biopsy showing compression, disruption and destruction of the glomerular basement membrane and b demonstrating
deposition of dark-staining silver granules (both x600)
Fig. 2 Electron micrograph of a single glomerular capillary loop
showing dense dots of sliver scattered within mesangium and
glomerular basement membranes (arrows) (magnification x4400)
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pulsed cyclophosphamide to treat her renal impairment.
She achieved a nadir creatinine of 288 μmol/l.
Conclusion
Irreversible silver exposure causing argyria (skin depos-
ition) and argyrosis (eye deposition) is well-recognised.
Current evidence for an effect of silver administration
on the kidney is limited. Studies of workers occupation-
ally exposed to silver have produced variable results:
Rosenman et al. [7] observed a significantly lower
creatinine clearance in precious metal manufacturing
workers, but could not exclude a contribution of cad-
mium and solvent exposure, and renal biopsies were not
performed. Pifer et al. [8] observed no impairment of
creatinine clearance in silver reclamation workers.
A number of case reports of renal impairment follow-
ing silver exposure have been published. However in
several the route of exposure was through the applica-
tion of topical silver sulfadiazine [2–4], the sulfadiazine
component in itself being potentially nephrotoxic, whilst
there were also other potentially confounding comorbid-
ities such as diabetes, hypertension [2] and severe burns
[3]. Watanabe et al. [5] reported an instance of nephrotic
syndrome and membranous glomerulonephropathy in a
patient who had had argyria for 8 years. More recently,
Mayr et al. [6] published a case of renal impairment in a
hypertensive patient who had been ingesting colloidal sil-
ver. His renal biopsy appearances were similar in part, with
deposited silver particles along the glomerular basement
membrane, but unlike our case glomerular damage was
limited to hypertensive and ischaemic glomerulosclerosis.
Crescentic glomerulonephritis results from disruption
of the glomerular basement membrane (GBM) which
may be induced by immune complexes or by cellular
mediators such as proteinases and reactive oxygen spe-
cies. Examples of damage to the GBM initiating a patho-
logical immune response by exposure of an immune
neo-epitope and subsequent crescentic glomeruloneph-
ritis include membranous glomerulonephritis [9] and
lithotripsy [10] in association with anti-GBM antibodies.
ANCA positive pauci-immune glomerulonephritis has
been previously described in a patient with intravascular
large B cell lymphoma who presented with livedo reticu-
laris and systemic symptoms of fever and lethargy how-
ever in this case renal excretory function was preserved
[11]. Hamidou et al. described 2 cases of ANCA vascu-
litis in the context of chronic lymphocytic leukaemia
and T cell lymphoma with both cutaneous vasculitis and
a pulmonary renal syndrome [12]. However, our patient
Fig. 3 Electron probe microanalysis of a granules and b background kidney. Silver was detected using energy dispersive analysis of X-rays (EDAX)
on the transmission electron microscope. Electron probe microanalysis of background kidney shows a relative absence of silver and selenium
atoms with much carbon. Analysis of the granules shows that they contain predominantly silver and some selenium atoms
Fig. 4 Silver electrode for production of colloidal silver suspension.
The device is shown switched on with electrodes placed in a beaker of
plain water which has turned cloudy following 15 min of electrolysis
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had no autoantibodies, and no deposited immunopro-
teins. Our case is unique in that it represents an ANCA
negative pauci-immune crescentic glomerulonephritis
with evidence of intense silver deposition along the
GBM in a patient with T cell lymphoma.
Although most cases of pauci-immune GN are associ-
ated with ANCA, between 5–10 % cases are ANCA nega-
tive. The pathogenesis in these cases may be related to
other autoantibodies (such as anti-endothelial antibodies)
or to direct leukocyte-induced GBM damage via soluble
mediators, which in this case may have been due to a
combination of T cell lymphoma and argyria. We demon-
strate that immunosuppressive therapy improved the situ-
ation and allowed cessation of haemodialysis, supporting a
hypothesis of an immune-mediated process most likely di-
rected towards the glomerular basement membrane asso-
ciated with silver deposition.
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